Admin
The nutraceuticals excipients markets will grow with a compound annual growth rate (CAGR) of 7.7 percent to $6.1 billion in 2028, according to MarketsandMarkets (Northbrook, IL).
The heightened demand for nutraceutical products is attributed to escalating consumer demand for natural and organic ingredients and heightened awareness of ingredient sourcing and quality. Additionally, the potential allergenic risks from synthetic excipients is further elevating the appeal of organic compounds as safer alternatives. Clean label products, ingredient transparency and simplicity are also driving manufacturers to integrate organic excipients into their formulations, according to MarketsandMarkets.
According to the report, there is an increasing demand for dry excipients, which allow for dosage flexibility including tablets, capsules, powders and granules. Dry excipients are compatible with an extensive array of active ingredients and are growing in popularity in both the nutraceutical and pharmaceutical industries.
Dry excipients are also more bioavailable due to their enhanced solubility and dissolution rates of active compounds. They also have high stability and a prolonged shelf life, protecting them from environmental factors. This allows dry excipients to meet consumer expectations for quality and longevity, MarketsandMarkets said.
According to the report, North America accounts for the largest share of the nutraceutical excipients market. This growth is attributed to increasing lifestyle diseases and health concerns, such as obesity and cardiovascular disease.
For more information and to request a copy of the full report, visit this link.
The nutraceuticals excipients markets will grow with a compound annual growth rate (CAGR) of 7.7 percent to $6.1 billion in 2028, according to MarketsandMarkets (Northbrook, IL).
The heightened demand for nutraceutical products is attributed to escalating consumer demand for natural and organic ingredients and heightened awareness of ingredient sourcing and quality. Additionally, the potential allergenic risks from synthetic excipients is further elevating the appeal of organic compounds as safer alternatives. Clean label products, ingredient transparency and simplicity are also driving manufacturers to integrate organic excipients into their formulations, according to MarketsandMarkets.
According to the report, there is an increasing demand for dry excipients, which allow for dosage flexibility including tablets, capsules, powders and granules. Dry excipients are compatible with an extensive array of active ingredients and are growing in popularity in both the nutraceutical and pharmaceutical industries.
Dry excipients are also more bioavailable due to their enhanced solubility and dissolution rates of active compounds. They also have high stability and a prolonged shelf life, protecting them from environmental factors. This allows dry excipients to meet consumer expectations for quality and longevity, MarketsandMarkets said.
According to the report, North America accounts for the largest share of the nutraceutical excipients market. This growth is attributed to increasing lifestyle diseases and health concerns, such as obesity and cardiovascular disease.
